Gilead's $2.2B Ouro buyout delivers autoimmune T-cell engager, new purpose for Galapagos

Clinical OMICsLeukemia Stem Cell Diversity Drives Treatment Resistance in AML

Clinical OMICsLymphoid Cancer Risk Linked to Long Telomeres and POT1 Mutations

FDA News ReleasesFDA Grants Seventh Approval under the National Priority Voucher Pilot Program

Endpoints NewsTrump plans to fire Makary from FDA role, according to reports

Endpoints NewsFDA Commissioner Makary to be fired, WSJ reports

FierceBiotechA protective gene sent to the liver cleared amyloid from mouse brains, sparking hope for an Alzheimer’s gene therapy

Endpoints NewsDaiichi Sankyo posts 'extraordinary loss' of nearly $1B

BioWorldMoney raised by biopharma

BioWorldBiopharma money raised: Jan. 1-May 7, 2026

BioWorldBioWorld and Nasdaq stock indices

BioWorldBiopharma money raised by month in 2026 (US$M)

BioWorldOther news to note for May 8, 2026